Can New Imaging Technologies Improve Patient Outcomes?

Viewing Information

Getting Started

Read all the information presented below. When ready select the "View Program" tab above.

Claiming Credits

To receive credits, participants must review the program materials in their entirety and complete the online post examination and evaluation. CME credits require a post examination score of 70% or higher. CE credits require a post examination score of 80% or higher.

System Hardware/Software and Internet Connection Requirements

The following information is provided for your reference in conjunction with review of this program.

General System and Internet Requirements:  Speakers or Headphones, High Speed Internet connection, Wireless 3G and 4G,
Web browsers: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher and Chrome.

Operating Systems:  Windows 2000 or higher, (MS Surface and other MS mobile devices compatible), MAC OSX 10.3 or higher, Mac iOS 5.0 or higher (iPad, iPhone compatible), Android 4.3 or higher (most Android mobile devices compatible).

Program Summary

As new technological advances in Computed Tomography continue to impact how healthcare professionals diagnose and treat patients with stroke, pancreatic and biliary cancer and other oncological disease; this program from RSNA 2017 features the following topics and speakers. Each will provide insight into how advanced imaging is improving patient outcomes.

Saving Brain and Improving Patient Outcomes with a Better Acute Stroke Protocol
Presented by Kenneth Snyder, M.D., PhD

Can UHR CT Improve Outcomes with Better Detection, Diagnosis and Staging of Pancreatic and Biliary Cancer
Presented by Miyuki Sone, M.D.

Improving Oncologic Outcomes Using a Unique 4DCT Solution
Presented by Junsung Choi, M.D.

Release Date: January 16, 2018
CME Expiration Date: January 15, 2020
CE Expiration Date: February 29, 2020
Format: Self Instructional - Audio Visual with Slides
Educational Credits:
Two (2) AMA/PRA Category 1 CME Credit™
Two (2) ARRT Category A CE Credit
Two (2) AHRA CRA Credit
Estimated Completion Time: 2 hours

This program was originally presented live at RSNA 2017 and sponsored by the Institute for Advanced Medical Education (IAME) and supported through an unrestricted educational grant from Toshiba America Medical Systems (now Canon Medical Systems USA, Inc.).

Target Audience & Cost

This program is intended for: Radiologists, Other MD's, Radiologic Technologists, Radiology Administrators and related Imaging Professionals.

There is no cost to participate in this program.

Educational Objectives

Upon completion of this CME activity the healthcare provider should be able to:

  1. Describe how advanced physiologic imaging is transforming the treatment of acute ischemic stroke.
  2. Describe the limitations of conventional CT in the diagnosis of pancreatic and biliary disease.
  3. Be familiar with the clinical utility of Ultra High Resolution CT Imaging.
  4. Describe how hybrid Angio/CT systems are providing clinical utility in interventional oncologic imaging.

No special educational preparation is required for this CME/CE Activity!

Speakers

Kenneth Snyder, M.D., PhD Kenneth Snyder, M.D., PhD
University at Buffalo Neurosurgery
Toshiba Stroke and Vascular Research Center
Gates Vascular Institute
Kaleida Health

Dr. Snyder joined UBNS in 2011 after completing his fellowship training in endovascular neurosurgery with UB Neurosurgery and spent 6 months as a research fellow at the Barrow Neurological Institute under Dr. Robert Spetzler.

He completed his neurosurgical residency at UB and received his PhD in biophysics under the guidance of Dr. Frederick Sachs specializing in mechanoelectric transduction of cellular membranes. He is trained in all general neurosurgical procedures, including brain tumor, spine, and peripheral nerve surgery.

Dr. Snyder’s extra training in open cerebrovascular techniques and well as his endovascular fellowship give him the necessary tool set for specialization in the comprehensive management of neurovascular pathology in both the brain and spinal cord, including treatment of aneurysms, arteriovenous malformations, arteriovenous fistulas, and stroke. He has special interests and expertise in physiological imaging of the brain and its use in the evaluation and management of acute stroke patients, as well as all endovascular techniques for acute stroke intervention for both extracranial and intracranial vascular occlusive disease.

Dr. Snyder has been awarded a Congress of Neurological Surgeons Vascular Fellowship for Cerebrovascular Research, a Toshiba Stroke Imaging Research Fellowship, the Gold Humanism in Excellence in Teaching, and been named the UB Neurosurgery Resident of the Year.

Miyuki Sone, M.D. Miyuki Sone, M.D.
National Cancer Center Hospital,
Tokyo, Japan

Miyuki Sone, MD, is a consultant radiologist at National Cancer Center Hospital in Japan. She earned her medical degree from Iwate Medical University and completed her training of internal medicine at Iwate Prefectural Central Hospital, followed by a fellowship of Radiology at Iwate Medical University. Before accepting her current position, she served as a staff and then an assistant professor at Iwate Medical University. She is a delegate of the Japanese Society of Interventional Radiology. She has had a longstanding interest in interventional oncology, IR for women’s health, and clinical trial methodology for IR.

Junsung Choi, M.D. Junsung Choi, M.D.
Department of Diagnostic Imaging and Interventional Radiology
Moffitt Cancer Center

Dr. Choi received his Doctor of Medicine Degree from the State University of New York, Upstate Medical University in Syracuse, New York. He completed his internship at St. Joseph’s Hospital Health Center in Syracuse, New York, his radiology residency at the Hospital of St. Raphael (affiliated with the Yale University School of Medicine) in New Haven, Connecticut and his fellowship at the University of South Florida College of Medicine in Tampa, Florida. Dr. Choi has been with Moffitt Cancer Center since 1994. He serves as PI and Co-PI on several grants and clinical trials.

Conflict of Interest Disclosure Policy

IAME requires everyone who is in a position to control the content of a CE/CME activity to disclose all relevant financial relationships with any commercial interest. This information is utilized to 1) determine if a conflict exists, 2) resolve the conflict by initiating a content validation process, and 3) advise learners of this information. Any individual who refuses to (or chooses not to) disclose relevant financial relationships will be disqualified from participating as an instructor, planner or manager and cannot have control of or responsibility for the development, management, presentation or evaluation of a CE/CME activity certified by IAME.

Disclosures

IAME received an educational grant in support of this program from Toshiba America Medical Systems (now Canon Medical Systems USA, Inc.).

Dr. Snyder discloses that UB Neurosurgery has the following to disclose: Research and consultant support: Boston Scientific, Cordis, EndoTex, EPI, Guidant, Medtronic, Micrus, Kerberos, Zimmer, Abbott Vascular, EV3, Toshiba. Significant Financial Interest: EndoTex, Micrus,BSC EPI, Access Closure Inc,Primus, Cordis. Major Stockholder: Boston Scientific, Access Closure Inc, Niagara Gorge Medical.

Dr. Sone discloses no relationships with Toshiba America Medical Systems (now Canon Medical Systems USA, Inc.) or any other commercial supporter.

Dr. Choi discloses no relationships with Toshiba America Medical Systems (now Canon Medical Systems USA, Inc.) or any other commercial supporter.

No individual at IAME who had control over the content of this program has relationships with Toshiba America Medical Systems (now Canon Medical Systems USA, Inc.) or any other commercial supporter.

Accreditation

The Institute for Advanced Medical Education (IAME) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Institute for Advanced Medical Education (IAME) designates this enduring material for a maximum of 2 AMA/PRA Category 1 CME Credits.™ Physicians should only claim credit commensurate with the extent of their participation in the activity.

Radiologic Technologists (Pending Review & Approval):
This course meets all criteria and has been approved by the AHRA, The Association for Medical Imaging Management for two (2) ARRT Category A CE Credit.

Radiology Administrators (Pending Review & Approval):
This course meets all CRA renewal credit criteria and has been approved for two (2) continuing education credit in the following CRA domains: Asset Resource Management (AM), Operations Management (OM) and Fiscal Management (FM).

For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board or other credentialing organization.

Method of Participation/Criteria for Success

CME Credits
To receive CME credits for participating in this CME activity you must successfully complete the online post examination with a passing score of 70% or higher.

CE Credits
To receive CE credits for participating in this CE activity you must successfully complete the online post examination with a passing score of 80% or higher.

Online examinations return an immediate grade report. Upon receiving a passing score click Continue and complete the evaluation form. To view and print your Statement of Credit click the Print/View Certificate button displayed from within your MyAR Archives page.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.